JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
The acquisition will strengthen the overall company’s position as leading global CRO services partner
USFDA completes PAI of Lupin’s biotech facility in Pune
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
The observations are of procedural in nature and will be responded to within the stipulated time
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
Eugia Steriles receives EIR from USFDA for new injectable facility
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Subscribe To Our Newsletter & Stay Updated
